Hims & Hers Health Price to Book Ratio 2020-2024 | HIMS

Historical price to book ratio values for Hims & Hers Health (HIMS) over the last 10 years. The current price to book ratio for Hims & Hers Health as of November 22, 2024 is 11.95.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Hims & Hers Health Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-21 24.15 11.95
2024-09-30 18.42 $2.02 9.12
2024-06-30 20.19 $1.67 12.09
2024-03-31 15.47 $1.61 9.63
2023-12-31 8.90 $1.61 5.52
2023-09-30 6.29 $1.55 4.06
2023-06-30 9.40 $1.52 6.19
2023-03-31 9.92 $1.49 6.64
2022-12-31 6.41 $1.50 4.29
2022-09-30 5.58 $1.50 3.73
2022-06-30 4.53 $1.54 2.94
2022-03-31 5.33 $1.59 3.35
2021-12-31 6.55 $1.63 4.01
2021-09-30 7.54 $1.74 4.33
2021-06-30 10.89 $1.52 7.18
2021-03-31 13.23 $1.53 8.66
2020-12-31 14.60 $-2.77 -5.27
2020-09-30 11.75 $0.82 14.33
2020-06-30 10.17 $0.85 11.94
2020-03-31 10.00 $0.85 11.73
2019-12-31 9.90 0.00
2019-09-30 9.87 $0.82 11.98
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.276B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.263B 0.00
Inspire Medical Systems (INSP) United States $5.580B 174.01
Enovis (ENOV) United States $2.580B 17.49
Privia Health (PRVA) United States $2.530B 210.80
IRhythm Technologies (IRTC) United States $2.313B 0.00
Azenta (AZTA) United States $2.227B 111.05
Omnicell (OMCL) United States $2.043B 66.83
Clover Health Investments (CLOV) United States $1.684B 0.00
10x Genomics (TXG) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.484B 0.00
Phreesia (PHR) United States $1.098B 0.00
Butterfly Network (BFLY) United States $0.701B 0.00
Standard BioTools (LAB) United States $0.603B 0.00
Talkspace (TALK) United States $0.559B 0.00
Fulgent Genetics (FLGT) United States $0.518B 0.00
Definitive Healthcare (DH) United States $0.491B 85.00
Health Catalyst (HCAT) United States $0.466B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
TruBridge (TBRG) United States $0.239B 69.61
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
American Well (AMWL) United States $0.123B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.075B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Zepp Health (ZEPP) China $0.038B 0.00
Movano (MOVE) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.010B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00